Edition:
United States

Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

7.11USD
19 Jan 2018
Change (% chg)

$-0.24 (-3.27%)
Prev Close
$7.35
Open
$7.34
Day's High
$7.40
Day's Low
$6.89
Volume
2,177,015
Avg. Vol
1,466,623
52-wk High
$14.45
52-wk Low
$5.77

Select another date:

Wed, Jan 3 2018

Endo unit settles case ahead of first state court testosterone trial

Endo International's Auxilium unit on Tuesday settled a lawsuit over its testosterone replacement drug, just days before the case was set to go to trial in what would have been the first such legal proceeding at the Philadelphia Court of Common Pleas.

Endo unit cleared of liability in first testosterone replacement trial

NEW YORK A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim.

Endo unit cleared of liability in first testosterone replacement trial

NEW YORK, Nov 16 A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim.

Select another date: